Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-Life Comparative Analysis of Robotic-Assisted Versus Laparoscopic Radical Prostatectomy in a Single Centre Experience.
Salciccia S, Santarelli V, Di Pierro GB, Del Giudice F, Bevilacqua G, Di Lascio G, Gentilucci A, Corvino R, Brunelli V, Basile G, Scornajenghi CM, Santodirocco L, Gobbi L, Rosati D, Moriconi M, Panebianco V, Magliocca FM, Santini D, Di Civita MA, Forte F, Frisenda M, Franco G, Sciarra A. Salciccia S, et al. Among authors: di civita ma. Cancers (Basel). 2024 Oct 25;16(21):3604. doi: 10.3390/cancers16213604. Cancers (Basel). 2024. PMID: 39518044 Free PMC article.
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1).
Santini D, Li H, Roviello G, Park SH, Grande E, Kucharz J, Basso U, Fiala O, Monteiro FSM, Poprach A, Buti S, Molina-Cerrillo J, Catalano M, Buchler T, Seront E, Ansari J, Myint ZW, Ghosn M, Calabrò F, Kopp RM, Bhuva D, Bourlon MT, Roberto M, Di Civita MA, Mollica V, Marchetti A, Soares A, Battelli N, Ricci M, Kanesvaran R, Bamias A, Porta C, Massari F, Santoni M. Santini D, et al. Among authors: di civita ma. Target Oncol. 2024 Nov;19(6):893-903. doi: 10.1007/s11523-024-01096-3. Epub 2024 Sep 17. Target Oncol. 2024. PMID: 39289313
Immunotherapy-Based Combinations in First-Line Urothelial Cancer: A Systematic Review and Individual Patient Data (IPD) Meta-Analysis.
Di Civita MA, Torchia A, Santini D, Marinelli D, Magro V, Cerro M, Pappalardo L, Maltese G, Santamaria F, Zacco L, Buccilli D, Dehghanpour A, Speranza I, Sciarra A, Panebianco V, Roberto M. Di Civita MA, et al. Curr Oncol. 2024 Aug 20;31(8):4713-4727. doi: 10.3390/curroncol31080352. Curr Oncol. 2024. PMID: 39195335 Free PMC article.
Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments.
Santamaria F, Roberto M, Buccilli D, Di Civita MA, Giancontieri P, Maltese G, Nicolella F, Torchia A, Scagnoli S, Pisegna S, Barchiesi G, Speranza I, Botticelli A, Santini D. Santamaria F, et al. Among authors: di civita ma. Crit Rev Oncol Hematol. 2024 Aug;200:104405. doi: 10.1016/j.critrevonc.2024.104405. Epub 2024 Jun 3. Crit Rev Oncol Hematol. 2024. PMID: 38838928 Review.
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials.
Marinelli D, Gallina FT, Pannunzio S, Di Civita MA, Torchia A, Giusti R, Gelibter AJ, Roberto M, Verrico M, Melis E, Tajè R, Cecere FL, Landi L, Nisticò P, Porciello N, Occhipinti M, Brambilla M, Forde PM, Liu SV, Botticelli A, Novello S, Ciliberto G, Cortesi E, Facciolo F, Cappuzzo F, Santini D. Marinelli D, et al. Among authors: di civita ma. Crit Rev Oncol Hematol. 2023 Dec;192:104190. doi: 10.1016/j.critrevonc.2023.104190. Epub 2023 Oct 21. Crit Rev Oncol Hematol. 2023. PMID: 37871779 Free article.
The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.
Carconi C, Cerreti M, Roberto M, Arrivi G, D'Ambrosio G, De Felice F, Di Civita MA, Iafrate F, Lucatelli P, Magliocca FM, Picchetto A, Picone V, Catalano C, Cortesi E, Tombolini V, Mazzuca F, Tomao S. Carconi C, et al. Among authors: di civita ma. Crit Rev Oncol Hematol. 2023 Jun;186:103990. doi: 10.1016/j.critrevonc.2023.103990. Epub 2023 Apr 13. Crit Rev Oncol Hematol. 2023. PMID: 37061075 Review.